吳 思遠

Medicine & Life Sciences

1. Chemoradiotherapy 100%
2. Cohort Studies 88%
3. Radiotherapy 84%
4. Propensity Score 75%
5. Intensity-Modulated Radiotherapy 74%
6. Adenocarcinoma 57%
7. Population 52%
8. Hydroxymethylglutaryl-CoA Reductase Inhibitors 51%
9. Neoplasms 49%
10. Squamous Cell Carcinoma 45%
11. Confidence Intervals 45%
12. Squamous Cell Carcinoma of Head and Neck 41%
13. Survival 40%
14. Comorbidity 37%
15. Mortality 37%
16. Neoplasm Metastasis 33%
17. fucoidan 32%
18. Esophageal Squamous Cell Carcinoma 31%
19. Drug Therapy 28%
20. Hepatocellular Carcinoma 28%
21. Therapeutics 28%
22. Databases 26%
23. Head and Neck Neoplasms 24%
24. Mouth 24%
25. Prostatic Neoplasms 24%
26. Thorax 24%
27. Human Influenza 24%
28. Registries 24%
29. Chronic Obstructive Pulmonary Disease 24%
30. Induced Hyperthermia 23%
31. Colon 22%
32. Regression Analysis 22%
33. Mastication 22%
34. Adenocarcinoma of Lung 22%
35. MicroRNAs 22%
36. Colonic Neoplasms 21%
37. Vaccination 20%
38. Prostatectomy 20%
39. Sutton disease 2 19%
40. Image-Guided Radiotherapy 19%
41. Elderly 18%
42. ErbB Receptors 18%
43. Survival Rate 18%
44. Radiation Pneumonitis 18%
45. Breast Neoplasms 18%
46. Apoptosis 18%
47. Androgens 17%
48. Cytoreduction Surgical Procedures 16%
49. Adjuvant Chemotherapy 16%
50. Case-Control Studies 16%